Drug resistance and genomic variations among Mycobacterium tuberculosis isolates from The Nile Delta, Egypt

• Published in: Scientific reports Vol. 14; no. 1; pp. 20401 - 9
• Main Authors: Soliman, May S., Hansen, Chungyi H., Hanafy, Mostafa, Shawky, Sherine, Rashed, Heba, Abdullah, Mohamed, Soliman, Noha Salah, Gad, Maha A., Khairat, Sahar, El-Kholy, Amani, Talaat, Adel M.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 02.09.2024; Nature Publishing Group; Nature Portfolio
• Subjects: 631/326/2521; 692/699/255/1856; Adult; Antitubercular Agents - pharmacology; Clinical isolates; DNA sequencing; Drug resistance; Drug Resistance, Bacterial - genetics; Drug Resistance, Multiple, Bacterial - genetics; Egypt; Egypt - epidemiology; Ethambutol; Female; Genetic Variation; Genome, Bacterial; Genome-wide variations; Genomics; Humanities and Social Sciences; Humans; Isoniazid; Isoniazid - pharmacology; Lineages; Male; Microbial Sensitivity Tests; Middle Aged; multidisciplinary; Mutation; Mycobacterium tuberculosis; Mycobacterium tuberculosis - drug effects; Mycobacterium tuberculosis - genetics; Mycobacterium tuberculosis - isolation & purification; Public health; Rifampin; Science; Science (multidisciplinary); Streptomycin; Streptomycin - pharmacology; Tuberculosis; Tuberculosis, Multidrug-Resistant - epidemiology; Tuberculosis, Multidrug-Resistant - microbiology; Whole genome sequencing; Whole Genome Sequencing - methods; Egypt; Genome-wide variations; Lineages; Tuberculosis; Drug resistance; Egypt
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-024-70199-8

Tuberculosis is a global public health concern. Earlier reports suggested the emergence of high rates of drug resistant tuberculosis in Egypt. This study included 102 isolates of Mycobacterium tuberculosis collected from two reference laboratories in Cairo and Alexandria. All clinical isolates were sub-cultured on Löwenstein–Jensen medium and analyzed using both BD BACTEC MGIT 960 SIRE Kit and standard diffusion disk assays to identify the antibiotic sensitivity profile. Extracted genomic DNA was subjected to whole genome sequencing (WGS) using Illumina platform. Isolates that belong to lineage 4 represented > 80%, while lineage 3 represented only 11% of the isolates. The percentage of drug resistance for the streptomycin, isoniazid, rifampicin and ethambutol were 31.0, 17.2, 19.5 and 20.7, respectively. Nearly 47.1% of the isolates were sensitive to the four anti-tuberculous drugs, while only one isolate was resistant to all four drugs. In addition, several new and known mutations were identified by WGS. High rates of drug resistance and new mutations were identified in our isolates. Tuberculosis control measures should focus on the spread of mono (S, I, R, E)- and double (S, E)-drug resistant strains present at higher rates throughout the whole Nile Delta, Egypt.